Comparison of Inducibility of Multidrug Resistance (MDR)1, Multidrug Resistance-Associated Protein (MRP)1, and MRP2 mRNAs by Prototypical Microsomal Enzyme Inducers in Primary Cultures of Human and Cynomolgus Monkey Hepatocytes
This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducer...
Saved in:
Published in | Biological & Pharmaceutical Bulletin Vol. 31; no. 11; pp. 2068 - 2072 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Pharmaceutical Society of Japan
01.11.2008
Pharmaceutical Society of Japan Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) in primary cultures of cryopreserved human and cynomolgus monkey hepatocytes. Analysis was performed by real-time reverse transcription-polymerase chain reaction using primers and TaqMan probes. First, the time course of the mRNA expression of these transporters in primary cultures of human and cynomolgus monkey hepatocytes was examined in detail. The ratio of MDR1 and MRP2 mRNA to β-actin mRNA in both human and cynomolgus monkey hepatocytes remained constant from 48 to 72 h and from 24 to 72 h of culture, respectively. Second, the hepatocytes were exposed to the inducers and the changes in the levels of the transporter mRNAs were examined. Rif increased MDR1 and MRP1 mRNA levels in both human and cynomolgus monkey hepatocytes, while Ome slightly increased MDR1 and MRP1 mRNA levels in cynomolgus monkey hepatocytes. Rif and Ome increased MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes. In contrast, Dex tended to decrease the mRNA levels of MDR1, MRP1, and MRP2 in both human and cynomolgus monkey hepatocytes. Cynomolgus monkey hepatocytes appeared to be more responsive than human hepatocytes to the inducers. These results indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of MDR1, MRP1, and MRP2 mRNAs in preclinical studies. |
---|---|
AbstractList | This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) in primary cultures of cryopreserved human and cynomolgus monkey hepatocytes. Analysis was performed by real-time reverse transcription-polymerase chain reaction using primers and TaqMan probes. First, the time course of the mRNA expression of these transporters in primary cultures of human and cynomolgus monkey hepatocytes was examined in detail. The ratio of MDR1 and MRP2 mRNA to β-actin mRNA in both human and cynomolgus monkey hepatocytes remained constant from 48 to 72 h and from 24 to 72 h of culture, respectively. Second, the hepatocytes were exposed to the inducers and the changes in the levels of the transporter mRNAs were examined. Rif increased MDR1 and MRP1 mRNA levels in both human and cynomolgus monkey hepatocytes, while Ome slightly increased MDR1 and MRP1 mRNA levels in cynomolgus monkey hepatocytes. Rif and Ome increased MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes. In contrast, Dex tended to decrease the mRNA levels of MDR1, MRP1, and MRP2 in both human and cynomolgus monkey hepatocytes. Cynomolgus monkey hepatocytes appeared to be more responsive than human hepatocytes to the inducers. These results indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of MDR1, MRP1, and MRP2 mRNAs in preclinical studies. This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) in primary cultures of cryopreserved human and cynomolgus monkey hepatocytes. Analysis was performed by real-time reverse transcription-polymerase chain reaction using primers and TaqMan probes. First, the time course of the mRNA expression of these transporters in primary cultures of human and cynomolgus monkey hepatocytes was examined in detail. The ratio of MDR1 and MRP2 mRNA to β-actin mRNA in both human and cynomolgus monkey hepatocytes remained constant from 48 to 72h and from 24 to 72h of culture, respectively. Second, the hepatocytes were exposed to the inducers and the changes in the levels of the transporter mRNAs were examined. Rif increased MDR1 and MRP1 mRNA levels in both human and cynomolgus monkey hepatocytes, while Ome slightly increased MDR1 and MRP1 mRNA levels in cynomolgus monkey hepatocytes. Rif and Ome increased MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes. In contrast, Dex tended to decrease the mRNA levels of MDR1, MRP1, and MRP2 in both human and cynomolgus monkey hepatocytes. Cynomolgus monkey hepatocytes appeared to be more responsive than human hepatocytes to the inducers. These results indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of MDR1, MRP1, and MRP2 mRNAs in preclinical studies. This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and multidrug resistance-associated protein 2 (MRP2) following exposure to the prototypical microsomal enzyme inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) in primary cultures of cryopreserved human and cynomolgus monkey hepatocytes. Analysis was performed by real-time reverse transcription-polymerase chain reaction using primers and TaqMan probes. First, the time course of the mRNA expression of these transporters in primary cultures of human and cynomolgus monkey hepatocytes was examined in detail. The ratio of MDR1 and MRP2 mRNA to beta-actin mRNA in both human and cynomolgus monkey hepatocytes remained constant from 48 to 72 h and from 24 to 72 h of culture, respectively. Second, the hepatocytes were exposed to the inducers and the changes in the levels of the transporter mRNAs were examined. Rif increased MDR1 and MRP1 mRNA levels in both human and cynomolgus monkey hepatocytes, while Ome slightly increased MDR1 and MRP1 mRNA levels in cynomolgus monkey hepatocytes. Rif and Ome increased MRP2 mRNA levels in both human and cynomolgus monkey hepatocytes. In contrast, Dex tended to decrease the mRNA levels of MDR1, MRP1, and MRP2 in both human and cynomolgus monkey hepatocytes. Cynomolgus monkey hepatocytes appeared to be more responsive than human hepatocytes to the inducers. These results indicate that primary cultures of cynomolgus monkey hepatocytes are as useful as primary cultures of human hepatocytes for evaluating the induction of MDR1, MRP1, and MRP2 mRNAs in preclinical studies. |
Author | Morikawa, Hiroshi Satoh, Tetsuo Naito, Shinsaku Nishimura, Masuhiro Koeda, Akiko Narimatsu, Shizuo |
Author_xml | – sequence: 1 fullname: Nishimura, Masuhiro organization: Research and Development Center, Otsuka Pharmaceutical Factory, Inc – sequence: 2 fullname: Koeda, Akiko organization: Ina Research Inc – sequence: 3 fullname: Morikawa, Hiroshi organization: Ina Research Inc – sequence: 4 fullname: Satoh, Tetsuo organization: Ina Research Inc – sequence: 5 fullname: Narimatsu, Shizuo organization: Laboratory of Health Chemistry, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University – sequence: 6 fullname: Naito, Shinsaku organization: Research and Development Center, Otsuka Pharmaceutical Factory, Inc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18981575$$D View this record in MEDLINE/PubMed |
BookMark | eNptkU2P0zAQhiO0iP2AE3dkCQmBIMUfcewcS9mlK22hquBsOY5TXBI72Mkh_F3-CE7TZSXExR5rnnlnPO9lcmad1UnyHMEFwhl_X3blgqAFhjl_lFwgkrGUYkTPkgtYIJ7miPLz5DKEA4SQQUyeJOeIFxxRRi-S3yvXdtKb4CxwNbi11aBMaRrTj9N7MzS9qfywBzsdTOilVRq83nzcvUHv_ptMlyE4ZWSvK7D1rtfGRn63nXhpKxBDDNrd52UA5XgkXD92RskGbIzyLrg2htf219jqeRrtA4giW29a6Uewik0Hr8M03XpopT3KrkbrWtfshwA2zv7QI1jrTvZOjb0OT5PHtWyCfna6r5JvN9dfV-v07sun29XyLlV5AfuUEq45g2WWKUIVq2XNK6YZyzVFJZY1hKQoEMMFpzWheUlwmSFIc1KRouRZTq6SV7Nu593PQYdetCYo3TTSajcEkRcsIxixCL78Bzy4wds4m0BZVpCc4mKi3s7UtJbgdS26eQcCQTE5L6LzgiAxOR_pFyfNoWx19cCerI7AzQzE7LRvZxtj9UNnFVhpXOOiHOQifhYhJCDKj_LxYDiL389wFPowCx2i5Xv9t5P0vVGNvp8qVs_nsf4-qb5LL7QlfwB8RNpo |
CitedBy_id | crossref_primary_10_1038_s41574_022_00745_9 crossref_primary_10_3109_00498254_2012_751517 crossref_primary_10_1124_dmd_111_042754 crossref_primary_10_3892_ol_2012_1014 crossref_primary_10_1179_1120009X12Z_00000000010 crossref_primary_10_3390_molecules22040600 crossref_primary_10_1007_s40262_017_0506_8 crossref_primary_10_1002_bdd_2111 crossref_primary_10_1016_j_dmpk_2019_04_003 crossref_primary_10_7717_peerj_12594 crossref_primary_10_1016_j_ejphar_2009_11_051 crossref_primary_10_1016_j_toxicon_2021_02_012 crossref_primary_10_1016_j_dmpk_2016_05_004 crossref_primary_10_3892_mmr_2015_4458 crossref_primary_10_3109_03602531003654915 crossref_primary_10_1248_yakushi_129_815 |
Cites_doi | 10.1053/cp.1999.v66.a101944 10.1124/dmd.32.8.834 10.1016/S0378-4274(01)00306-X 10.1067/mcp.2001.113697 10.2133/dmpk.17.253 10.2133/dmpk.20.46 10.2133/dmpk.21.297 10.1016/0005-2736(76)90160-7 10.2133/dmpk.23.45 10.2133/dmpk.22.178 10.1248/bpb.28.886 10.1248/bpb.26.1052 10.1038/sj.bjp.0706830 10.1124/jpet.103.061713 10.2133/dmpk.21.19 10.1016/S0014-5793(99)01295-8 10.1074/jbc.M010173200 10.2133/dmpk.20.452 10.1101/gr.GR-1649R 10.1177/014860710402800101 10.1016/j.bbrc.2006.06.012 10.1172/JCI6663 10.1248/bpb.29.1032 10.1248/yakushi.122.339 10.1016/S0091-679X(08)61797-5 10.1093/jnci/92.16.1295 10.1042/0264-6021:3400585 |
ContentType | Journal Article |
Copyright | 2008 The Pharmaceutical Society of Japan Copyright Japan Science and Technology Agency 2008 |
Copyright_xml | – notice: 2008 The Pharmaceutical Society of Japan – notice: Copyright Japan Science and Technology Agency 2008 |
CorporateAuthor | aResearch and Development Center Otsuka Pharmaceutical Factory Inc cNon-Prfit Organization Human & Animal Bridging Research Institute Ichikawa General Hospital dLaboratory of Health Chemistry Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University bIna Research Inc |
CorporateAuthor_xml | – name: aResearch and Development Center Otsuka Pharmaceutical Factory Inc – name: bIna Research Inc – name: cNon-Prfit Organization Human & Animal Bridging Research Institute Ichikawa General Hospital – name: dLaboratory of Health Chemistry Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
DOI | 10.1248/bpb.31.2068 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5215 |
EndPage | 2072 |
ExternalDocumentID | 3121396111 10_1248_bpb_31_2068 18981575 cs7biolo_2008_003111_016_2068_2072499142 article_bpb_31_11_31_11_2068_article_char_en |
Genre | Journal Article Comparative Study |
GroupedDBID | --- 1CY 23N 2WC 53G 5GY 6J9 ABTAH ACGFO ACIWK ACPRK ADBBV AENEX AFFNX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 DIK DU5 E3Z EBS EJD F5P GX1 HH5 JMI JSF JSH KQ8 MOJWN OK1 P2P RJT RZJ TKC TR2 VH1 XSB ZY4 .55 ABJNI X7M ZXP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c690t-538e870b44c35c7faf8d7e776e51b2af00399172985f356b32b410563d39b8463 |
ISSN | 0918-6158 |
IngestDate | Thu Aug 15 22:41:22 EDT 2024 Thu Oct 10 17:47:07 EDT 2024 Fri Dec 06 01:39:13 EST 2024 Sat Sep 28 08:36:04 EDT 2024 Fri Nov 08 06:52:50 EST 2024 Thu Aug 17 20:28:22 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c690t-538e870b44c35c7faf8d7e776e51b2af00399172985f356b32b410563d39b8463 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/bpb/31/11/31_11_2068/_article/-char/en |
PMID | 18981575 |
PQID | 1449365297 |
PQPubID | 1966364 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_69743217 proquest_journals_1449365297 crossref_primary_10_1248_bpb_31_2068 pubmed_primary_18981575 medicalonline_journals_cs7biolo_2008_003111_016_2068_2072499142 jstage_primary_article_bpb_31_11_31_11_2068_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2008-11-01 |
PublicationDateYYYYMMDD | 2008-11-01 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Biological & Pharmaceutical Bulletin |
PublicationTitleAlternate | Biol Pharm Bull |
PublicationYear | 2008 |
Publisher | The Pharmaceutical Society of Japan Pharmaceutical Society of Japan Japan Science and Technology Agency |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan – name: Japan Science and Technology Agency |
References | 10) Mills J. B., Rose K. A., Sadagopan N., Sahi J., de Morais S. M., J. Pharmacol. Exp. Ther., 309, 303—309 (2004). 20) Morioka Y., Nishimura M., Imai T., Suzuki S., Harada M., Satoh T., Naito S., Drug Metab. Pharmacokinet., 21, 19—28 (2006). 23) Kubitz R., Warskulat U., Schmitt M., Häussinger D., Biochem. J., 340, 585—591 (1999). 3) Dean M., Rzhetsky A., Allikmets R., Genome Res., 11, 1156—1166 (2001). 25) FDA, “Draft Guidance for Industry: Drug Interaction Studies—Study Design, Data Analysis, and Implications for Dosing and Labeling,” Sep., 2006. 19) Nishimura M., Ueda N., Naito S., Biol. Pharm. Bull., 26, 1052—1056 (2003). 1) Juliano R. L., Ling, V., Biochim. Biophys. Acta, 455, 152—162 (1976). 8) Han Y., Sugiyama Y., Biol. Pharm. Bull., 29, 1032—1035 (2006). 5) Eyal S., Lamb J. G., Smith-Yockman M., Yagen B., Fibach E., Altschuler Y., White H. S., Bialer M., Br. J. Pharmacol., 149, 250—260 (2006). 15) Nishimura M., Koeda A., Shimizu T., Nakayama M., Satoh T., Narimatsu S., Naito S., Drug Metab. Pharmacokinet., 23, 45—53 (2008). 18) Nishimura M., Naito S., Drug Metab. Pharmacokinet., 20, 452—477 (2005). 11) Nishimura M., Yoshitsugu H., Naito S., Hiraoka I., Yakugaku Zasshi, 122, 339—361 (2002). 16) Nishimura M., Naito S., Biol. Pharm. Bull., 28, 886—892 (2005). 17) Nishimura M., Koeda A., Suzuki E., Shimizu T., Kawano Y., Nakayama M., Satoh T., Narimatsu S., Naito S., Biochem. Biophys. Res. Commun., 346, 1033—1039 (2006). 7) Tazuke Y., Kiristioglu I., Heidelberger K. P., Eisenbraun M. D., Teitelbaum D. H., J. Parenter. Enteral Nutr., 28, 1—6 (2004). 12) Nishimura M., Koeda A., Suzuki E., Kawano Y., Nakayama M., Satoh T., Narimatsu S., Naito S., Drug Metab. Pharmacokinet., 21, 297—307 (2006). 21) Schrenk D., Baus P. R., Ermel N., Klein C., Vorderstemann B., Kauffmann H. M., Toxicol. Lett., 120, 51—57 (2001). 22) Turncliff R. Z., Meier P. J., Brouwer K. L., Drug Metab. Dispos., 32, 834—839 (2004). 24) Courtois A., Payen L., Guillouzo A., Fardel O., FEBS Lett., 459, 381—385 (1999). 26) Greiner B., Eichelbaum M., Fritz P., Kreichgauer H. P., von Richter O., Zundler J., Kroemer H. K., J. Clin. Invest., 104, 147—153 (1999). 6) Nishimura M., Yamaguchi M., Yamauchi A., Ueda N., Naito S., Drug Metab. Pharmacokinet., 20, 46—54 (2005). 14) Nishimura M., Koeda A., Suganuma Y., Suzuki E., Shimizu T., Nakayama M., Satoh T., Narimatsu S., Naito S., Drug Metab. Pharmacokinet., 22, 178—186 (2007). 2) Borst P., Evers R., Kool M., Wijnholds J., J. Natl. Cancer Inst., 92, 1295—1302 (2000). 28) Johne A., Brockmöller J., Bauer S., Maurer A., Langheinrich M., Roots I., Clin. Pharmacol. Ther., 66, 338—345 (1999). 9) Geick A., Eichelbaum M., Burk O., J. Biol. Chem., 276, 14581—14587 (2001). 4) Tsuji A., Drug Metab. Pharmacokinet., 17, 253—274 (2002). 13) Seglen P. O., Methods Cell Biol., 13, 29—83 (1976). 27) Hamman M. A., Bruce M. A., Haehner-Daniels B. D., Hall S. D., Clin. Pharmacol. Ther., 69, 114—121 (2001). 22 23 24 25 26 27 28 Eyal S., Lamb J. G., Smith-Yockman (5) 2006; 149 10 11 12 13 Juliano R. L., Ling, V. (1) 1976; 455 14 15 16 17 18 19 3 4 Tazuke Y., Kiristioglu I., Heidelbe (7) 2004; 28 6 Borst P., Evers R., Kool M., Wijnho (2) 2000; 92 8 9 20 21 |
References_xml | – ident: 28 doi: 10.1053/cp.1999.v66.a101944 – ident: 22 doi: 10.1124/dmd.32.8.834 – ident: 21 doi: 10.1016/S0378-4274(01)00306-X – ident: 27 doi: 10.1067/mcp.2001.113697 – ident: 4 doi: 10.2133/dmpk.17.253 – ident: 6 doi: 10.2133/dmpk.20.46 – ident: 12 doi: 10.2133/dmpk.21.297 – volume: 455 start-page: 152 year: 1976 ident: 1 publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2736(76)90160-7 contributor: fullname: Juliano R. L., Ling, V. – ident: 15 doi: 10.2133/dmpk.23.45 – ident: 14 doi: 10.2133/dmpk.22.178 – ident: 16 doi: 10.1248/bpb.28.886 – ident: 19 doi: 10.1248/bpb.26.1052 – volume: 149 start-page: 250 issn: 0007-1188 year: 2006 ident: 5 publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0706830 contributor: fullname: Eyal S., Lamb J. G., Smith-Yockman – ident: 10 doi: 10.1124/jpet.103.061713 – ident: 20 doi: 10.2133/dmpk.21.19 – ident: 24 doi: 10.1016/S0014-5793(99)01295-8 – ident: 9 doi: 10.1074/jbc.M010173200 – ident: 18 doi: 10.2133/dmpk.20.452 – ident: 3 doi: 10.1101/gr.GR-1649R – volume: 28 start-page: 1 issn: 0148-6071 year: 2004 ident: 7 publication-title: J. Parenter. Enteral Nutr. doi: 10.1177/014860710402800101 contributor: fullname: Tazuke Y., Kiristioglu I., Heidelbe – ident: 17 doi: 10.1016/j.bbrc.2006.06.012 – ident: 26 doi: 10.1172/JCI6663 – ident: 8 doi: 10.1248/bpb.29.1032 – ident: 11 doi: 10.1248/yakushi.122.339 – ident: 13 doi: 10.1016/S0091-679X(08)61797-5 – volume: 92 start-page: 1295 year: 2000 ident: 2 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/92.16.1295 contributor: fullname: Borst P., Evers R., Kool M., Wijnho – ident: 23 doi: 10.1042/0264-6021:3400585 – ident: 25 |
SSID | ssj0007023 ssib023156946 ssib002483627 ssib002822050 ssib017383521 |
Score | 2.0141726 |
Snippet | This study investigated the changes in the mRNA levels of the ATP binding cassette (ABC) transporters multidrug resistance 1 (MDR1), multidrug... |
SourceID | proquest crossref pubmed medicalonline jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2068 |
SubjectTerms | Animals ATP Binding Cassette Transporter, Subfamily B, Member 1 - biosynthesis Cells, Cultured Cryopreservation cynomolgus monkey Dexamethasone - pharmacology Enzyme Induction Female hepatocyte Hepatocytes - drug effects Hepatocytes - enzymology Hepatocytes - metabolism Humans induction Macaca fascicularis Microsomes, Liver - drug effects Microsomes, Liver - enzymology multidrug resistance 1 multidrug resistance-associated protein 1 multidrug resistance-associated protein 2 Multidrug Resistance-Associated Proteins - biosynthesis Omeprazole - pharmacology Reverse Transcriptase Polymerase Chain Reaction Rifampin - pharmacology RNA, Messenger - biosynthesis Species Specificity |
Title | Comparison of Inducibility of Multidrug Resistance (MDR)1, Multidrug Resistance-Associated Protein (MRP)1, and MRP2 mRNAs by Prototypical Microsomal Enzyme Inducers in Primary Cultures of Human and Cynomolgus Monkey Hepatocytes |
URI | https://www.jstage.jst.go.jp/article/bpb/31/11/31_11_2068/_article/-char/en http://mol.medicalonline.jp/en/journal/download?GoodsID=cs7biolo/2008/003111/016&name=2068-2072e https://www.ncbi.nlm.nih.gov/pubmed/18981575 https://www.proquest.com/docview/1449365297 https://search.proquest.com/docview/69743217 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Biological and Pharmaceutical Bulletin, 2008/11/01, Vol.31(11), pp.2068-2072 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEF_aKiiIaGv1tOp-KEXppd5m88QPUk6lCFeO4wr9FvLY2LMmOS4Jkv67_iPO7OZ1ekL1S2iTnWnSnd_szuw8CDlko0DXbcE1FoWmZoANofmwisvTx9jxRRgH6BqYnFtnF8aXS_Nya3vYi1oqi-AkvNmYV_I_swr3YF4xS_YfZrZlCjfgZ5hfuMIMw_VWczzuNxE8xi4coQp2lcfmMrc2WpUyvA63iYhh2FBOPs7A_mfSFbphiNbMmJBpBNgNU1LNpg2VjM2YTfXjZHZ-muMGFsdlRbWUMz7BGL88S7BicXpTJUK9GWYKA6tpXd5C1fJUJW_VSQKyHVdplmTfv5Y5ahtQMLAuLv0iC6uiDnZsDqAXrdZG4V1erbnmg35RcXXqcrVIStlT6Xji5-XVYpW1a00mIuVdvl5ct3cn2Wpx7f-QD85gNDBovVHwQtIbNRdFXmZrjhOnziDseUCZA5azqhx_IpT-54YNtrnKMG0WCM76QGB9dT-ynN7WQR-pNkR_LEu6gakWwTI44eiTaIj6xb9_W5TbUEk00oDcA2KPMw-Jt8kdLPtoyGWoM_bskWxm2H5WnY0KxO96f3lt_3X3G0gW1pZ4kKhjQVWe5e_Wltx1zR-Rh7W5RE-V7D8mWyLdJXunKcxAUtEjKgOY5cnQLrk3bpoX7pKjqRKIakjnXYZhPpQkbbH2ao_87DBEs5j2MYS_twChHUDoG0DQWzbc-LCHHlqjB8bPpjgeBJwibqjEDQ0q2scN7XBDFW5ogxsKTGrc0AY3-HYSN5JthxuqcEN7uHlCLj5_mo_PtLrxiRZa7qjQYBMiYB0NDCPkZmjHfuxEtrBtS5gs0P0YE-pdsDxcx4y5aQVcDzBa2-IRdwMwKPg-2UmzVDwjVDdsEI3Id31gh-aaFYJm5j42rzT1SAzIYSMO3lJ9iLdB5AbkvRKVdlCt9JpBjNVXHN0-xMxRUNQD8mFNvrxah-ZemNuy2FzdDRd2GMACg04lG8STAV9q6ANy0EhkR8wMw-WWqbv2gLxuH4Og4Zmnn4qszD3LBRNJZzDiqZLj7isd12FgrD6_3X_gBbnfKZEDslOsSvES7JEieCVh-Avpwjoq |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | ABC ChemistRy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Inducibility+of+Multidrug+Resistance+%28MDR%291%2C+Multidrug+Resistance-Associated+Protein+%28MRP%291%2C+and+MRP2+mRNAs+by+Prototypical+Microsomal+Enzyme+Inducers+in+Primary+Cultures+of+Human+and+Cynomolgus+Monkey+Hepatocytes&rft.jtitle=Biological+%26+pharmaceutical+bulletin&rft.au=Nishimura%2C+Masuhiro&rft.au=Koeda%2C+Akiko&rft.au=Morikawa%2C+Hiroshi&rft.au=Satoh%2C+Tetsuo&rft.date=2008-11-01&rft.issn=0918-6158&rft.eissn=1347-5215&rft.volume=31&rft.issue=11&rft.spage=2068&rft.epage=2072&rft_id=info:doi/10.1248%2Fbpb.31.2068&rft.externalDBID=n%2Fa&rft.externalDocID=10_1248_bpb_31_2068 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-6158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-6158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-6158&client=summon |